Bank of New York Mellon’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.6M | Buy |
436,020
+184,873
| +74% | +$5.79M | ﹤0.01% | 1724 |
|
2025
Q1 | $8.43M | Buy |
251,147
+204,550
| +439% | +$6.86M | ﹤0.01% | 1931 |
|
2024
Q4 | $1.83M | Sell |
46,597
-2,294
| -5% | -$89.9K | ﹤0.01% | 2780 |
|
2024
Q3 | $1.92M | Sell |
48,891
-2,363
| -5% | -$93K | ﹤0.01% | 2754 |
|
2024
Q2 | $2M | Sell |
51,254
-15,656
| -23% | -$610K | ﹤0.01% | 2792 |
|
2024
Q1 | $2.88M | Buy |
66,910
+251
| +0.4% | +$10.8K | ﹤0.01% | 2574 |
|
2023
Q4 | $3.07M | Sell |
66,659
-100,690
| -60% | -$4.64M | ﹤0.01% | 2608 |
|
2023
Q3 | $5.72M | Sell |
167,349
-44,392
| -21% | -$1.52M | ﹤0.01% | 2243 |
|
2023
Q2 | $8.15M | Buy |
211,741
+12,354
| +6% | +$476K | ﹤0.01% | 2050 |
|
2023
Q1 | $7.14M | Sell |
199,387
-188,973
| -49% | -$6.76M | ﹤0.01% | 2108 |
|
2022
Q4 | $15.3M | Sell |
388,360
-49,285
| -11% | -$1.94M | ﹤0.01% | 1692 |
|
2022
Q3 | $15.8M | Sell |
437,645
-125,542
| -22% | -$4.53M | ﹤0.01% | 1634 |
|
2022
Q2 | $17.1M | Sell |
563,187
-16,021
| -3% | -$487K | ﹤0.01% | 1622 |
|
2022
Q1 | $17.7M | Sell |
579,208
-212,317
| -27% | -$6.49M | ﹤0.01% | 1743 |
|
2021
Q4 | $24.7M | Sell |
791,525
-143,118
| -15% | -$4.47M | ﹤0.01% | 1594 |
|
2021
Q3 | $14.3M | Sell |
934,643
-899
| -0.1% | -$13.7K | ﹤0.01% | 1919 |
|
2021
Q2 | $17.4M | Sell |
935,542
-22,611
| -2% | -$421K | ﹤0.01% | 1811 |
|
2021
Q1 | $17.2M | Buy |
958,153
+8,915
| +0.9% | +$160K | ﹤0.01% | 1788 |
|
2020
Q4 | $14.6M | Buy |
949,238
+202,435
| +27% | +$3.11M | ﹤0.01% | 1804 |
|
2020
Q3 | $8.27M | Sell |
746,803
-47,886
| -6% | -$530K | ﹤0.01% | 1955 |
|
2020
Q2 | $9.97M | Buy |
794,689
+118,813
| +18% | +$1.49M | ﹤0.01% | 1844 |
|
2020
Q1 | $7.66M | Buy |
675,876
+429,613
| +174% | +$4.87M | ﹤0.01% | 1847 |
|
2019
Q4 | $3.23M | Sell |
246,263
-3,987
| -2% | -$52.3K | ﹤0.01% | 2567 |
|
2019
Q3 | $2.26M | Buy |
250,250
+22,711
| +10% | +$205K | ﹤0.01% | 2685 |
|
2019
Q2 | $2.24M | Buy |
+227,539
| New | +$2.24M | ﹤0.01% | 2738 |
|